Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07114874 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Name: NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia — clinical trial record (NCT07114874)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorNeurocrine Biosciences

Started2025-07-11

View on ClinicalTrials.gov ↗

Amendment history

2026-09-26

Trial sites expanded: 57 → 61 locations

2026-06-04

Study Status, Contacts/Locations v4

Study sites55→57

2026-05-13

Study Status, Study Design, Contacts/Locations v3

Enrollment reduced: 800 → 600 participants

Study sites53→55

2026-04-10

Study Status, Contacts/Locations v2

Study sites24→53

2025-10-20

Study Status, Contacts/Locations v1

Study sites2→24

2025-08-06

Original filing

Neurocrine Biosciences

25 trials monitored

See 1 trial at risk

Schizophrenia

675 trials monitored

See 32 trials at risk

This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.

Trial Details

NCT Number	NCT07114874
Lead Sponsor	Neurocrine Biosciences
Conditions	Schizophrenia
Enrollment	600 participants
Start Date	2025-07-11
Primary Completion	2031-12 (estimated)
Study Completion	2031-12 (estimated)
Updated on ClinicalTrials.gov	2026-09-25